Bahrain approves Pfizer/BioNTech COVID-19 vaccine use


By ELydf
  • World
  • Saturday, 05 Dec 2020

MANAMA, Dec. 4 (Xinhua) -- Bahrain's health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine.

"Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups," said the National Health Regulatory Authority (NHRA).

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

US cites progress in meeting with Ukraine officials, sets further talks
Australian authorities urge thousands to flee New South Wales bushfires
Russian drones, missiles hit railway hub near Ukraine's capital, railway says
India caps airfares as IndiGo crisis leaves hundreds stranded for fifth day
FIFA faces backlash after awarding first Peace Prize to Donald Trump
UN agency says Chornobyl nuclear plant's protective shield damaged
Canada removes Syria from its list of foreign state supporters of terrorism
Spain to slaught 30,000 pigs amid swine fever control measures
U.S. stocks close higher
2025 Poland "Chinese Film Festival" opens in Warsaw

Others Also Read